Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

BCL2L1 antibody (AA 3-14)

This Mouse Monoclonal antibody specifically detects BCL2L1 in WB and IHC (f). It exhibits reactivity toward Human.
Catalog No. ABIN6936485

Quick Overview for BCL2L1 antibody (AA 3-14) (ABIN6936485)

Target

See all BCL2L1 Antibodies
BCL2L1 (BCL2-Like 1 (BCL2L1))

Reactivity

  • 235
  • 135
  • 119
  • 51
  • 25
  • 12
  • 10
  • 10
  • 5
  • 5
  • 4
  • 2
  • 2
  • 1
Human

Host

  • 170
  • 94
  • 1
Mouse

Clonality

  • 152
  • 113
Monoclonal

Conjugate

  • 137
  • 27
  • 11
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This BCL2L1 antibody is un-conjugated

Application

  • 179
  • 99
  • 65
  • 61
  • 56
  • 43
  • 32
  • 28
  • 28
  • 27
  • 20
  • 14
  • 10
  • 7
  • 6
  • 4
  • 3
  • 3
  • 2
  • 2
Western Blotting (WB), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

BX006
  • Binding Specificity

    • 29
    • 25
    • 19
    • 16
    • 16
    • 15
    • 12
    • 10
    • 8
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 3-14

    Specificity

    Recognizes a protein of 27 kDa, identified as the Bcl-X protein. This MAb shows no cross-reaction with Bcl-2 or Bax protein. Bcl-X has two isoforms, Bcl-XL (long), a 241 amino acid protein which suppresses cell death. And Bcl-XS (short), a 178 amino acid protein lacking a 63 amino acid domain which functions as a dominant inhibitor of Bcl-2. This MAb reacts with both Bcl-XS and Bcl-XL proteins.

    Cross-Reactivity (Details)

    Human. Mouse. Rat. Pig.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    A synthetic peptide, aa 3-14 (Cys-QSNRELVVDFLS) of human Bcl-X protein.

    Isotype

    IgG2a kappa
  • Application Notes

    Known_Application: Western Blot (1-2ug/ml); Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 minutes at RT) (Staining of formalin-fixed tissues requires heating tissue sections in 1mM EDTA buffer, pH 7.5-8.5, for 45 min at 95°C followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Positive_Control: Jurkat, K562, HL-60 or HeLa cells. Reed-Sternberg cells in Hodgkin's lymphoma.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    BCL2L1 (BCL2-Like 1 (BCL2L1))

    Alternative Name

    BCL2L1

    Background

    Apoptosis regulator Bcl-X, B cell lymphoma 2 like, BCL XL/S, Bcl-2-like protein 1, Bcl2-L-1, BCL2L, Bcl2l1, BCLX, BclXL, BclXs, Protein phosphatase 1 regulatory subunit 52 (PPP1R52),Bcl-X (Apoptosis Marker)
    Cellular localisation: Cytoplasmic and cell/nuclear membrane

    Molecular Weight

    27kDa

    Gene ID

    598, 516966

    UniProt

    Q07817

    Pathways

    Apoptosis, Negative Regulation of intrinsic apoptotic Signaling
You are here:
Chat with us!